标题：Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma
作者：Song, Yang; Wang, Qing; Wang, Desheng; Li, Junqiang; Yang, Jing; Li, Hong; Wang, Xiang; Jin, Xuerong; Jing, Ruirui; Yang, Jing-Hua; 更多 作者机构：[Song, Yang; Li, Junqiang; Yang, Jing; Li, Hong; Wang, Xiang; Jin, Xuerong; Su, Haichuan] Fourth Mil Med Univ, Tangdu Hosp, Dept Oncol, 569 Xinsi Rd, 更多
通讯作者：Su, HC;Yang, JH;Yang, JH;Yang, JH
通讯作者地址：[Su, HC]Fourth Mil Med Univ, Tangdu Hosp, Dept Oncol, 569 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China;[Yang, JH]Shandong Univ, Sch Med, Canc Res C 更多
摘要：Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with a high mortality rate and poor prognosis. However, little is known concerning the molecular mechanism of PDAC at the proteomics level. Here we report a proteomics analysis of PDAC tumor and adjacent tissues by shotgun proteomics followed by label-free quantification, and in total, 3031 and 3306 proteins were identified in three pairs of PDAC tumor and adjacent tissues, respectively; 40 of them were differentially expressed for at least three-fold in PDAC tumor tissues. Ontological and interaction network analysis highlighted the dysregulation of a set of four proteins in the carboxypeptidase family: carboxypeptidase A1 (CPA1), A2 (CPA2), B1 (CPB1), and chymotrypsin C (CTRC). Western blotting confirmed the downregulation of the carboxypeptidase network in PDAC. Immunohistochemistry of tissue microarray from 90 PDAC patients demonstrated that CPB1 was downregulated 7.07-fold (P < .0001, n = 81) in tumor comparing with the peritumor tissue. Further 208 pancreatic tissues from PDAC tumor, peritumor, and pancreatis confirmed the downregulation of CPB1 in the PDAC patients. Insummary, our results displayed that the expression of carboxypeptidase is significantly downregulated in PDAC tumor tissues and may be novel biomarker in the patient with PDAC.